Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Jul 27, 2023; 15(7): 1388-1396
Published online Jul 27, 2023. doi: 10.4240/wjgs.v15.i7.1388
Published online Jul 27, 2023. doi: 10.4240/wjgs.v15.i7.1388
Major complications after ultrasound-guided liver biopsy: An annual audit of a Chinese tertiary-care teaching hospital
Wei-Lu Chai, Dan-Lei Lu, Zhong-Xia Sun, Xin-Yan Jin, Tong-Long Zhang, Qiong Gao, Yu-Wei Pan, Qi-Yu Zhao, Tian-An Jiang, Department of Ultrasonography, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang Province, China
Chao Cheng, Zhuang Deng, Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang Province, China
Author contributions: Jiang TA and Chai WL contributed to conceptualization; Chai WL, Lu DL and Jiang TA contributed to data curation; Chai WL and Sun ZX contributed to formal analysis; Jiang TA contributed to funding acquisition and resources; Chai WL, Cheng C, Jin XY, Deng Z, Zhang TL, Zhao QY and Jiang TA contributed to investigation; Chai WL and Gao Q contributed to methodology; Jiang TA, Sun ZX, Zhao QY, Lu DL and Pan YW contributed to project administration; Chai WL and Lu DL contributed software; Zhao QY, Jiang TA and Sun ZX contributed to supervision; Chai WL and Jiang TA contributed to validation; Chai WL contributed to writing the original draft; Zhao QY and Jiang TA contributed to reviewing and editing.
Institutional review board statement: Ethical approval was obtained from the Clinical Research Ethics Committee of the First Affiliated Hospital, Zhejiang University School of Medicine before the study.
Informed consent statement: The requirement for informed consent was waived due to the retrospective nature of the study.
Conflict-of-interest statement: All the authors report having no relevant conflicts of interest for this article.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Tian-An Jiang, PhD, Chief Doctor, Researcher, Teacher, Department of Ultrasonography, The First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou 310003, Zhejiang Province, China. tiananjiang@zju.edu.cn
Received: February 11, 2023
Peer-review started: February 11, 2023
First decision: March 26, 2023
Revised: April 5, 2023
Accepted: May 6, 2023
Article in press: May 6, 2023
Published online: July 27, 2023
Processing time: 160 Days and 5.3 Hours
Peer-review started: February 11, 2023
First decision: March 26, 2023
Revised: April 5, 2023
Accepted: May 6, 2023
Article in press: May 6, 2023
Published online: July 27, 2023
Processing time: 160 Days and 5.3 Hours
Core Tip
Core Tip: Ultrasound-guided percutaneous liver biopsy has become a standard and important method in the management of liver disease. This annual audit confirmed that ultrasound-guided percutaneous liver biopsy is safely performed, with a major complication rate within the accepted range and in line with previously published data. Strict patient selection and peri-biopsy laboratory assessment are more important than procedural factors for optimizing the safety outcomes of this procedure.